Examine Injectable Drug Delivery Technologies, Targets and Therapeutics With This Essential and Comprehensive Report
Posted on: Wednesday, 1 October 2008, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/research/3edab7/injectable_drug_de) has announced the addition of the "Injectable Drug Delivery - Technologies, Targets and Therapeutics" report to their offering.
Second only to pills and capsules in terms of importance, injectable drug delivery - the administration of therapeutic drugs via injection - is an indispensable delivery method for numerous drugs critical to patient health and well-being. But within this segment, the sands are shifting as several factors converge to drive demand for delivery methods that increase safety, compliance and ease-of-use. While the economics of traditional disposable syringe devices remain compelling, a number of companies are combining synthetic materials and novel device designs to create devices with improved reliable and lower cost. Syringe designers and syringe makers must adapt their design focus from the caregiver to the lay user to address these changes and the opportunities they represent. This comprehensive and timely study is designed to provide drug company decision makers, injectable drug delivery participants, syringe device developers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, emerging therapies, and risk/reward scenario for injectable drug delivery. Designed and Written for market participants, the report contains the information necessary to identify and understand the growing importance of injectable drug delivery on self-administration, drug formulations, drug-device development, and therapeutic treatment protocols.
Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks:
-- Syringe & Injector profiles and analysis
-- Injectable Drug Delivery Segment Analysis
-- Injection Device Design Factors
-- Market Projections by Therapy
-- Industry Structure & Competitive Landscape
-- Emerging Therapies Opportunity/Risk Assessment
-- Injectable Drug Demand Drivers
-- Market Factors
-- Technology Factors
-- Regulatory Factors
Key Topics Covered: Executive Summary Injectable Drugs & the Leading Edge of Drug Therapeutics - Pipeline Drugs Represent Significant Opportunities - Demand Drivers - Diseases and Indications - Patient Demographics - Developing Economies - Market Factors - Managed Care and Healthcare Costs - Regulations and Regulatory Sentiment - Technology Drivers - Drug Stability - Drug Delivery Devices - Combination Products - Patient/Caregiver Sentiment Commercial Injection Device Assessment - Traditional Syringes - Safety Syringes - Needle-free Injectors - Pen Injectors - Prefilled Devices Diseases, Indications and Injectable Therapeutics - Hematopoietics - Important Indications - Competition for a $14 Billion Market - Anti-Inflammatory - Important Indications - Blockbuster Drugs Dominate the Sector - Pipeline and Outlook - Immune Modulators - Important Indications - Rapidly Expanding Targets and Indications - Pipeline and Outlook - Anticoagulants - Important Indications - Lovenox Continues to Dominate - Pipeline and Outlook - Growth Hormones - Important Indications - Strong Competition for Market Share - Pipeline and Outlook - Reproductive Medicine - Important Indications - Gonal -f % Follistim Drive Sector Beyond $1 Billion - Pipeline and Outlook Market Factors - FDA Regulations - Clinical Trials - Rx-to-OTC Switching - Impact of Generics Profiles of Market Participants
For more information visit http://www.researchandmarkets.com/research/3edab7/injectable_drug_de
Source: Business Wire
Related Articles
- Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
- Prefilled Syringes - Drugs, Devices and Disease Therapeutics Analyzes Eleven Important Prefilled Syringe Therapeutic Segments
- Research and Markets: The Buckeye Partners, L.P., Pipeline Operations Asset Summary Report Examines Its Key Business Structure and Operations, History and Products
- CPEX Pharmaceuticals and Serenity Pharmaceuticals Announce Collaboration on Drug Candidate for Urology Indication
- New Biopharma Company Appian Labs, LLC Provides Drug Design and Delivery Solutions
- California Biotechnology Company Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial Using Rexin-G(TM), a Targeted Injectable Gene Delivery System
- CARIE at Front of Statewide Effort to Counter Drug Industry Marketing
- Worldwide Telecommunications Service Provider Equipment Market Forecasts Indicate That the Market Will Be Worth $64.3 Billion By 2012
- Drugs From Sanofi-Aventis, Alizyme, and Arena Will Propel Obesity Drug Treatment Market to Over $1.5 Billion By 2014
- VELCADE(R) (Bortezomib) for Injection Studies Results Indicate Potential Utility Across the Multiple Myeloma Treatment Paradigm
 |
 |
User Comments (0)
RSS Feeds